Novo Nordisk Stock Falls, Sanofi Rises On Drug DelayShares of Novo Nordisk (NVO) plummeted more than 13% and Sanofi (SNY) rose 2% in early trading Monday, a day after Novo announced that its challenger to one of Sanofi's leading diabetes drugs has hit a roadblock. The FDA said it won't approve Novo's long-acting insulin candidate degludec until it gets more data assessing the possible heart risks associated with the drug. This was a surprise since the FDA went beyond the recommendations that its
Source:
Novo Nordisk Stock Falls, Sanofi Rises On Drug DelayLinkback:
https://tubagbohol.mikeligalig.com/index.php?topic=68690.0
Topic: Technology: Novo Nordisk Stock Falls, Sanofi Rises On Drug Delay (Read 379 times)